UVA-riboflavin photochemical therapy of bacterial keratitis: A pilot study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 1, 2012, Pages 95-102

  Makdoumi, Karim ^a   Mortensen, Jes ^a,b   Sorkhabi, Omid ^b   Malmvall, Bo Eric ^b,c   Crafoord, Sven ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

CXL; Keratitis; Pilot study; Riboflavin; Ultraviolet; UV; UVA

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN; CORTICOSTEROID; DEXAMETHASONE; EYE PROTEIN; FUSIDIC ACID; LEVOFLOXACIN; MOXIFLOXACIN; RIBOFLAVIN; RICROLIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA ULCER; CORYNEBACTERIUM INFECTION; CROSS LINKING; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; KERATITIS; KERATOCONUS; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZATION; PILOT STUDY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RADIATION EXPOSURE; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; ULTRAVIOLET A RADIATION; UVEITIS; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CONJUNCTIVA; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 84857359468     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1754-1     Document Type: Article

References (47)

1. Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F (2006) Microbial keratitis predisposing factors and morbidity. Ophthalmology 113:109-116 (Pubitemid 43021736)
2. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L (2003) Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87:834-838 (Pubitemid 36765243)
3. Wong T, Ormonde S, Gamble G, McGhee CN (2003) Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 87:1103-1108 (Pubitemid 37064885)
4. McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ (1995) The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 102:1943-1948 (Pubitemid 26004453)
5. Ibrahim YW, Boase DL, Cree IA (2009) Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol 93:1319-1324
6. Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27:22-27
7. Saeed A, D'Arcy F, Stack J, Collum LM, Power W, Beatty S (2009) Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea 28:285-292
8. Jeng BH, Gritz DC, Kumar AB, Holsclaw DS, Porco TC, Smith SD, Whitcher JP, Margolis TP, Wong IG (2010) Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol 128:1022-1028
9. McGowan JE Jr (2006) Resistance in nonfermenting Gramnegative bacteria: multidrug resistance to the maximum. Am J Med 119:S29-S36, discussion S62-70 (Pubitemid 43776143)
10. Harris AD, McGregor JC, Furuno JP (2006) What infection control interventions should be undertaken to control multidrugresistant Gram-negative bacteria? Clin Infect Dis 43(Suppl 2): S57-S61 (Pubitemid 44267141)
11. Rice LB (2007) Emerging issues in the management of infections caused by multidrug-resistant Gram-negative bacteria. Cleve Clin J Med 74(Suppl 4):S12-S20
12. Falagas ME, Bliziotis IA (2007) Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29:630-636 (Pubitemid 46710354)
13. Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47). pii:19045
14. Bertino JS (2009) Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 3:507-521
15. Betanzos-Cabrera G, Juarez-Verdayes MA, Gonzalez-Gonzalez G, Cancino-Diaz ME, Cancino-Diaz JC (2009) Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res 42:43-48
16. Ramos-Esteban JC, Bamba S, Jeng BH (2008) Treatment of multidrug-resistant Flavobacterium indologenes keratitis with trimethoprim-sulfamethoxazole. Cornea 27:1074-1076
17. Moshirfar M, Meyer JJ, Espandar L (2007) Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 33:1978-1981 (Pubitemid 47615385)
18. de la Cruz J, Behlau I, Pineda R (2007) Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourthgeneration fluoroquinolone therapy. J Cataract Refract Surg 33:1318-1321 (Pubitemid 46951014)
19. Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356-360 (Pubitemid 44215044)
20. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T (2010) Longterm results of riboflavin ultraviolet a corneal collagen crosslinking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol 149:585-593
21. Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-ainduced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620-627 (Pubitemid 36457967)
22. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE (2008) Collagen crosslinking with riboflavin and ultraviolet-a light in keratoconus: long-term results. J Cataract Refract Surg 34:796-801 (Pubitemid 351615507)
23. Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR (2008) A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg 24:S720-S725
24. Vinciguerra P, Camesasca FI, Albe E, Trazza S (2009) Corneal collagen cross-linking for ectasia after excimer laser refractive surgery: 1-year results. J Refract Surg: 1-12
25. Mazzotta C, Traversi C, Baiocchi S, Sergio P, Caporossi T, Caporossi A (2006) Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol 16:530-535
26. Ashwin PT, McDonnell PJ (2010) Collagen cross-linkage: a comprehensive review and directions for future research. Br J Ophthalmol 94:965-970
27. Schnitzler E, Sporl E, Seiler T (2000) Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients. Klin Monbl Augenheilkd 217:190-193
28. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27:590-594
29. Micelli Ferrari T, Leozappa M, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19:295-297
30. Moren H, Malmsjo M, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29:102-104
31. Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light A therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118:324-331
32. Makdoumi K, Mortensen J, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29:1353-1358
33. Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402-3408
34. Schrier A, Greebel G, Attia H, Trokel S, Smith EF (2009) In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg 25:S799-S802
35. Makdoumi K, Backman A, Mortensen J, Crafoord S (2010) Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol 248:207-212
36. Goodrich RP, Edrich RA, Li J, Seghatchian J (2006) The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 35:5-17 (Pubitemid 44354317)
37. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (2004) Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion (Paris) 44:877-885 (Pubitemid 38738418)
38. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R (2006) Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 90:85-91 (Pubitemid 43381495)
39. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R (2007) Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 37:131-137 (Pubitemid 350181574)
40. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA (2010) Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion (Paris) 50:1019-1027
41. Wollensak G, Spoerl E, Wilsch M, Seiler T (2004) Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/ UVA treatment. Cornea 23:43-49 (Pubitemid 38031874)
42. Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE (2006) Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg 32:279-283
43. Dhaliwal JS, Kaufman SC (2009) Corneal collagen cross-linking: a confocal, electron, and light microscopy study of eye bank corneas. Cornea 28:62-67
44. Spoerl E, Wollensak G, Dittert DD, Seiler T (2004) Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica 218:136-140 (Pubitemid 38338477)
45. Wollensak G, Spoerl E, Seiler T (2003) Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet- A-induced cross-linking. J Cataract Refract Surg 29:1780-1785 (Pubitemid 37210617)
46. Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35-40 (Pubitemid 39389439)
47. Wang F (2008) UVA/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica 222:369-372